Skip to main content
Review article - Peer-reviewed, 2021

Novel Strategies to Target Mast Cells in Disease

Paivandy, Aida; Pejler, Gunnar


Mast cells (MCs) are versatile effector cells of the immune system, characterized by a large content of secretory granules containing a variety of inflammatory mediators. They are implicated in the host protection toward various external insults, but are mostly well known for their detrimental impact on a variety of pathological conditions, including allergic disorders such as asthma and a range of additional disease settings. Based on this, there is currently a large demand for therapeutic regimens that can dampen the detrimental impact of MCs in these respective pathological conditions. This can be accomplished by several strategies, including targeting of individual mediators released by MCs, blockade of receptors for MC-released compounds, inhibition of MC activation, limiting mast cell growth or by inducing mast cell apoptosis. Here, we review the currently available and emerging regimens to interfere with harmful mast cell activities in asthma and other pathological settings and discuss the advantages and limitations of such strategies.


Apoptosis; Cytotoxicity; Inflammation; Mast cells

Published in

Journal of Innate Immunity
2021, volume: 13, pages: 131-147
Publisher: KARGER

Authors' information

Paivandy, Aida
Uppsala University
Uppsala University
Swedish University of Agricultural Sciences, Department of Anatomy, Physiology and Biochemistry (AFB)

UKÄ Subject classification

Immunology in the medical area

Publication Identifiers


URI (permanent link to this page)